The pharmaceutical industry requires serious revamping if we are going to provide more effective solutions for all demographics. One way to ensure that the industry moves in that direction is to improve the diversity of clinical-stage trials, so we sat down with Del Smith founder of Acclinate; a dynamic business using data and AI to help improve the diversity of clinical research.